Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Primary analysis of the confirmatory VISION cohort C Meeting Abstract
| Authors: | Thomas, M.; Garassino, M.; Felip, E.; Sakai, H.; Le, X.; Veillon, R.; Smit, E.; Mazieres, J.; Cortot, A.; Raskin, J.; Viteri, S.; Yang, J. C. H.; Ahn, M. J.; Wu, Y. L.; Ma, R.; Zhao, J.; O'Brate, A.; Berghoff, K.; Bruns, R.; Otto, G.; Paik, P. |
| Abstract Title: | Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Primary analysis of the confirmatory VISION cohort C |
| Meeting Title: | 2022 World Conference on Lung Cancer |
| Keywords: | met inhibitor; tepotinib; met exon 14 skipping |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 17 |
| Issue: | 9 Suppl. |
| Meeting Dates: | 2022 Aug 6-9 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-09-01 |
| Start Page: | S9 |
| End Page: | S10 |
| Language: | English |
| ACCESSION: | WOS:000858678100015 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2022.07.024 |
| Notes: | Meeting Abstract: OA03.05 -- Source: Wos |
